Drug intelligence / Profile preview

68Ga-mNP-N

Development stage
Preclinical
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

68Ga-mNP-N is a dual-targeted diagnostic radiopharmaceutical nanoparticle developed for the PET/MRI imaging of prostate cancer. It consists of magnetic iron oxide nanoparticles (mNP) functionalized with amine (-NH2) groups, which are conjugated to pharmacophores targeting both prostate-specific membrane antigen (PSMA) and gastrin-releasing peptide receptors (GRPR). Labeled with the positron-emitting radioisotope Gallium-68 (68Ga), the agent enables high-sensitivity PET imaging, while the iron oxide core provides contrast for magnetic resonance imaging (MRI). This dual-receptor targeting strategy is designed to enhance the detection of prostate cancer lesions that may heterogeneously express PSMA and GRPR, potentially improving diagnostic sensitivity and specificity in cell lines such as LNCaP and PC-3.

Other names
68Ga-labeled amine-functionalized magnetic iron oxide nanoparticles68Ga-mNP-N1/2
02

Targets

GRPR (Gastrin-releasing peptide receptor)PSMA (Prostate-specific membrane antigen)

Beyond the preview

Go deeper on 68Ga-mNP-N.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 68Ga-mNP-N.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call